tiprankstipranks
Trending News
More News >
Biotricity Inc (BTCY)
OTHER OTC:BTCY
US Market
Advertisement

Biotricity (BTCY) Earnings Dates, Call Summary & Reports

Compare
118 Followers

Earnings Data

Report Date
Aug 18, 2025
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
-0.49
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Jul 17, 2025|
% Change Since: 20.51%|
Earnings Call Sentiment|Positive
The earnings call highlighted significant progress in strategic partnerships, market expansion, and financial performance, including revenue growth and positive adjusted EBITDA. However, despite these achievements, the company still faced a net loss, and the long sales cycles may delay future revenue gains.
Company Guidance -
Q1 2026
In the recent earnings call, Biotricity provided guidance on its fiscal year 2025 performance, highlighting revenue growth, strategic partnerships, and advancements in technology. The company reported a 16.5% year-over-year revenue increase for the fourth quarter, reaching $3.7 million, and an annual revenue rise of 14.3% to $13.8 million. Their gross profit for the quarter rose by 31% to $3 million, with a gross margin improvement to 80.4%. Operating expenses decreased by 24.5% to $13 million for the fiscal year, with significant reductions in SG&A and R&D expenses. The call emphasized Biotricity's progress toward profitability and positive adjusted EBITDA, which reached $438,000 in the last quarter. The company's strategic focus on expanding its Cardiac AI cloud platform and securing FDA clearance for its AI clinical model aims to enhance diagnostic accuracy and patient outcomes. Additionally, international market expansions, including regulatory approval in Canada and Saudi Arabia, are expected to contribute to future revenue growth.
Expansion of Cardiac AI Cloud Platform
Biotricity expanded its Cardiac AI cloud platform, leveraging over 1 trillion heartbeats of anonymized data, and partnered with Amazon AWS and Google's TensorFlow to enhance diagnostic accuracy and patient outcomes.
Strategic Partnerships and Market Reach
Biotricity formed alliances with three top GPOs, accessing 90% of US hospitals, and received approvals in Canada and Saudi Arabia, expanding its market reach.
Revenue and Profit Growth
For the fourth quarter, revenue increased by 16.5% year-over-year to $3.7 million, and for the fiscal year, revenue rose by 14.3% to $13.8 million. Gross profit improved by 31%, and operating expenses decreased by 24.5%.
Positive Adjusted EBITDA
Achieved positive adjusted EBITDA of $438,000 in the last quarter of fiscal 2025, marking a significant milestone towards profitability.
Launch of HeartSecure Service
Biotricity launched HeartSecure, a direct-to-consumer heart health screening service, targeting the $1.1 billion home heart health market.

Biotricity (BTCY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BTCY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2025
2026 (Q1)
- / -
-0.49
Jul 17, 2025
2025 (Q4)
-0.09 / -0.08
-0.075-6.67% (>-0.01)
Feb 20, 2025
2025 (Q3)
-0.11 / -0.05
-0.33984.07% (+0.29)
Nov 15, 2024
2025 (Q2)
- / -0.07
-0.4483.41% (+0.37)
Aug 21, 2024
2025 (Q1)
- / -0.07
-0.4181.71% (+0.33)
Jun 27, 2024
2024 (Q4)
-0.36 / -0.47
-0.5616.07% (+0.09)
Feb 21, 2024
2024 (Q3)
-0.44 / -0.34
-0.5437.22% (+0.20)
Nov 14, 2023
2024 (Q2)
-0.34 / -0.44
-0.56421.99% (+0.12)
Aug 15, 2023
2024 (Q1)
- / -
-0.51
Jun 30, 2023
2023 (Q4)
-0.41 / -0.41
-0.5119.61% (+0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BTCY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 17, 2025
$0.38$0.39+2.63%
Feb 20, 2025
$0.66$0.64-3.03%
Nov 15, 2024
$0.40$0.45+12.50%
Aug 21, 2024
$0.48$0.42-12.50%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Biotricity Inc (BTCY) report earnings?
Biotricity Inc (BTCY) is schdueled to report earning on Aug 18, 2025, Before Open (Confirmed).
    What is Biotricity Inc (BTCY) earnings time?
    Biotricity Inc (BTCY) earnings time is at Aug 18, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BTCY EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis